204 related articles for article (PubMed ID: 9492564)
21. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.
Kobak S; Oksel F; Aksu K; Kabasakal Y
Int J Rheum Dis; 2013 Feb; 16(1):88-92. PubMed ID: 23441777
[TBL] [Abstract][Full Text] [Related]
22. Primary Sjogren's syndrome: rarity in India.
Misra R; Hissaria P; Tandon V; Aggarwal A; Krishnani N; Dabadghao S
J Assoc Physicians India; 2003 Sep; 51():859-62. PubMed ID: 14710969
[TBL] [Abstract][Full Text] [Related]
23. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
24. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
Maeno N; Takei S; Imanaka H; Oda H; Yanagi K; Hayashi Y; Miyata K
J Rheumatol; 2001 Apr; 28(4):860-4. PubMed ID: 11327263
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
26. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
27. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
29. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
30. Sjögren's syndrome with anticentromere antibodies.
Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of labial salivary biopsy in Sjogren's syndrome: report of 182 cases].
Andretta M; Ianniello A; Ostuni PA; Siniscalchi E; Cusatelli P; Todesco S
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1):40-6. PubMed ID: 7597901
[TBL] [Abstract][Full Text] [Related]
32. Sjögren's syndrome in childhood.
Anaya JM; Ogawa N; Talal N
J Rheumatol; 1995 Jun; 22(6):1152-8. PubMed ID: 7674246
[TBL] [Abstract][Full Text] [Related]
33. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
34. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
35. Are there clinical or serological differences between male and female patients with primary Sjögren's syndrome?
Díaz-López C; Geli C; Corominas H; Malat N; Diaz-Torner C; Llobet JM; De La Serna AR; Laiz A; Moreno M; Vázquez G
J Rheumatol; 2004 Jul; 31(7):1352-5. PubMed ID: 15229956
[TBL] [Abstract][Full Text] [Related]
36. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].
Meyer O; Haim T
Nouv Presse Med; 1981 Jun; 10(26):2179-84. PubMed ID: 6973748
[TBL] [Abstract][Full Text] [Related]
37. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
38. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
[TBL] [Abstract][Full Text] [Related]
39. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
[TBL] [Abstract][Full Text] [Related]
40. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]